Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Arrowhead Pharmaceuticals initiates phase I study of ARO-ANG3

Dec. 27, 2018

Shenzhen Salubris Pharmaceuticals describes DPP-IV inhibitors for diabetes

Dec. 27, 2018

Identification and evaluation of novel dual inhibitors of sodium-dependent glucose cotransporters

Dec. 27, 2018

Suglat Tablets approved for additional indication of type 1 diabetes mellitus in Japan

Dec. 24, 2018

Combination approach revs up beta cell production

Dec. 24, 2018

Ionis begins phase I/II study of ION-TTR-LRx in healthy subjects and patients with hATTR

Dec. 24, 2018

Topline data presented from phase I studies of LX-2761

Dec. 21, 2018

Carmot initiates phase I study of CT-868

Dec. 21, 2018

Silence Therapeutics adds LP(a)-targeting siRNA medicine SLN-360 to preclinical pipeline

Dec. 20, 2018

Lilly begins phase III study of tirzepatide in patients with type 2 diabetes and cardiovascular risk

Dec. 20, 2018

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...